Back to Search
Start Over
<scp>CSF</scp> Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in <scp>PD</scp> and <scp>DLB</scp>
- Source :
- Movement disorders 36(11), 2595-2604 (2021). doi:10.1002/mds.28704
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- Background Molecular pathways associated with α-synuclein proteostasis have been detected in genetic studies and in cell models and include autophagy, ubiquitin-proteasome system, mitochondrial homeostasis, and synaptic plasticity. However, we lack biomarkers that are representative for these pathways in human biofluids. Objective The objective of this study was to evaluate CSF protein profiles of pathways related to α-synuclein proteostasis. Methods We assessed CSF protein profiles associated with neurotransmitter secretion, synapse plasticity, and autophagy in 2 monocentric cohorts with α-synucleinopathy (385 PD patients and 67 DLB patients). We included 80 PD patients and 17 DLB patients with variants in the glucocerebrosidase gene to serve as proxy for accelerated α-synuclein pathology with pronounced clinical trajectories. Results (1) Proteins associated with neurotransmitter secretion, synaptic plasticity, and endolysosomal autophagy were lower in PD and DLB patients compared with healthy controls. (2) These patterns were more pronounced in DLB than in PD patients, accentuated by GBA variant status in both entities. (3) CSF levels of these proteins were positively associated with CSF levels of total α-synuclein, with lower levels of proteostasis proteins related to lower levels of total α-synuclein. (4) These findings could be confirmed longitudinally. PD patients with low CSF profiles of proteostasis proteins showed lower CSF levels of α-synuclein longitudinally compared with PD patients with a normal proteostasis profile. Conclusion CSF proteins associated with neurotransmitter secretion, synaptic plasticity, and endolysosomal autophagy might serve as biomarkers related to α-synuclein proteostasis in PD and DLB. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- Subjects :
- Lewy Body Disease
0301 basic medicine
medicine.medical_specialty
metabolism [Parkinson Disease]
CSF
Neurotransmitter secretion
Synapse
03 medical and health sciences
0302 clinical medicine
Lysosome
Internal medicine
mental disorders
Autophagy
Humans
Medicine
ddc:610
metabolism [alpha-Synuclein]
CSF albumin
Neurotransmitter Agents
Neuronal Plasticity
synaptic plasticity
business.industry
Parkinson Disease
nervous system diseases
secretion
030104 developmental biology
Proteostasis
Endocrinology
medicine.anatomical_structure
Neurology
Synaptic plasticity
lysosome
alpha-Synuclein
Glucosylceramidase
PD
GBA
Neurology (clinical)
business
Glucocerebrosidase
Biomarkers
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 15318257 and 08853185
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Movement Disorders
- Accession number :
- edsair.doi.dedup.....c707618edca256b695b627b108102313